PROFILE |
 |
So, you don't want a hole in your head? Somanetics sells the INVOS Cerebral Oximeter, a noninvasive device that monitors blood-oxygen levels in the brain, primarily during surgical procedures. Based on Somanetics' in vivo optical spectroscopy (INVOS) technology, the device's SomaSensors attach to each side of the patient's forehead, and the firm's proprietary software displays oxygen levels on a computer screen. Somanetics markets to surgeons, anesthesiologists, and other health care providers in the US and in more than 45 foreign countries. The company is planning to license its technologies to other medical device manufacturers.
COMPETITION |
 |
Invivo Corporation (SAFE)
Respironics, Inc. (RESP)
Welch Allyn Protocol, Inc. (dossier)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: November
2000 Sales (mil.): 5.10
1-Yr. Sales Growth: 27.5%
Employees: 35
Revenue per employee: $145,714.29
KEY PEOPLE |
 |
Bruce J. Barrett
CEO
Bruce J. Barrett
CFO
CONTACT INFO |
 |
1653 E. Maple Rd.
Troy, MI 48083
US
Phone: 248-689-3050
Fax: 248-689-4272
Online: Web Site
|